In 2017, ViroCure was accepted as a resident company at the TBTI program at the University of South Florida. Our efforts in the United States are currently headquartered at USF's Moffitt Cancer Center.
ViroCure @ UMass Lowell
Our second research facility in the United States, working in close collaboration with other ViroCure labs around the world.
Osong Biovalley Facility
Secondary lab and GMP center under construction in Osong Biovalley in South Korea.
Yancheng Industrial Zone
ViroCure's operations in China will be based in offices and GMP labs sponsored by the provincial government in the Yancheng Industrial Zone.